Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.66 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.53 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1596805 | 0.98 | FOLH1 (0.63) | FOLH1MRGPRX4CYP2D6CYP2C9HIF1A | |
| SCHEMBL28059303 | 0.85 | PLA2G4B (0.51) | FOLH1MRGPRX4KMT2ATP53NFKB1 | |
| SCHEMBL10622069 | 0.84 | L3MBTL1 (0.63) | FOLH1HIF1AHPGDSMN1; SMN2 | |
| SCHEMBL27649226 | 0.84 | FOLH1 (0.61) | FOLH1MRGPRX4CYP2D6CYP2C9HIF1A | |
| SCHEMBL8581943 | 0.84 | KMO (0.51) | FOLH1MRGPRX4KMT2AMEN1NPC1 | |
| SCHEMBL28410476 | 0.83 | FOLH1 (0.46) | FOLH1MRGPRX4KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL39676 | 0.83 | TSHR (0.47) | FOLH1MRGPRX4CA1CA2 | |
| SCHEMBL29472003 | 0.83 | TSHR (0.47) | FOLH1MRGPRX4CA1CA2 | |
| SCHEMBL70351 | 0.83 | FOLH1 (0.70) | FOLH1CYP2D6CYP2C9HIF1AANPEP | |
| SCHEMBL371526 | 0.83 | FOLH1 (0.70) | FOLH1MRGPRX4CYP2D6CYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 543 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119034686-A | Impurity removing material and preparation method and application thereof | 江苏鲁控环境科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118105488-A | Diagnosis and treatment prodrug for inducing tumor stem cell apoptosis as well as preparation method and application thereof | 东南大学 | 2024-05-31 | — | — | CN | claimed |
| CN-116716029-B | Long-acting antibacterial and antiviral polyester finishing paint and preparation method thereof | 中海油常州涂料化工研究院有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117603001-A | Method for selectively recovering toluene and amyl anthraquinone from alkaline cleaning wastewater | 宜昌苏鹏科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-116716029-A | Long-acting antibacterial and antiviral polyester finishing paint and preparation method thereof | 中海油常州涂料化工研究院有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-112646159-B | Preparation method of quaternary ammonium salt modified polyester resin for antibacterial powder coating | 浙江光华科技股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-112646159-A | Preparation method of quaternary ammonium salt modified polyester resin for antibacterial powder coating | 浙江光华科技股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-110981719-A | Preparation method of 3-carboxyl benzaldehyde | 黄石市利福达医药化工有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-109970582-A | A method of preparing the chloro- 3- methyl benzoic acid of 2- amino -5- | 苏州山青竹生物医药有限公司 | 2019-07-05 | — | — | CN | claimed |
| US-20070232514-A1 | STABILIZED LIQUID ENZYME COMPOSITION | NOVOZYMES A/S (DK) | 2007-10-04 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| EP-1404652-A4 | A NOVEL ALKALOID DERIVATIVE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | CHEMTECH RES INC (KR) | 2005-06-15 | — | — | EP | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1404652-A1 | A NOVEL ALKALOID DERIVATIVE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Chemtech Research Incorporation (KR) | 2004-04-07 | — | — | EP | claimed |
| WO-2002100824-A1 | A NOVEL ALKALOID DERIVATIVE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | CHEMTECH RESEARCH INCORPORATION (KR) | 2002-12-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | FOLH1 3917/4885MRGPRX4 544/4885CYP2D6 1222/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | FOLH1 4875/4885MRGPRX4 3647/4885CYP2D6 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.